COPD

Pharmacists can play a crucial role in promoting the flu vaccine to these patients by recognizing the characteristics of those who do not seek vaccinations.

Adherence is a major factor in outcomes for patients with chronic obstructive pulmonary disease.

AstraZeneca and GlaxoSmithKline are key players in the COPD market.

Chronic obstructive pulmonary disease market projected to reach $14.1 billion by 2025.

Women accounted for most of the hospitalization and in-hospital deaths.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

The action plan aims to reduce the burden of chronic obstructive pulmonary disease on patients and the healthcare system.

The risk of comorbid chronic obstructive pulmonary disorder in patients infected with HIV may be underestimated.

The study, presented at the European Respiratory Society International Congress in London, analyzed data on 409 patients with COPD from primary care practices in the Netherlands and Switzerland.

Community pharmacists can play a valuable role in preventing hospital readmissions through patient education and resolution of identified drug therapy problems, according to data reported in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Over the years, a number of landmark clinical studies on COPD have been published, shaping how we treat the disease today.

FPR-ZM1 was seen to reverse the inflammatory response lung disease in mice.

Potential drug may have a protective role in chronic obstructive pulmonary disease.

Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Patients who switched to Ultibro Breezhaler had an increase in lung function.

An initiative that lowered copays for prescription drugs also lowered hospitalizations by 40%

A simple questionnaire and testing can help identify more patients with chronic obstructive pulmonary disease.

Long-term oxygen treatment did not improve survival in patients with COPD with moderately low blood oxygen levels.

A component found in red wine and grapes may help manage inflammation caused by a bacterial pathogen associated with upper respiratory tract inflammatory diseases.

The rise in indoor temperatures worsened respiratory symptom scores and increased the use of recuse inhalers, a new study found.

COPD is the fourth leading cause of death in the United States, contributing to more than 120,000 deaths each year.

Focus on the early stages of chronic obstructive pulmonary disease could prevent long-term lung function loss.

The FDA has approved bevespi aerosphere inhalation aerosol for the long-term maintenance treatment of airflow obstruction in patients with COPD.

Risk of developing mental health issues were found to be lower in chronic obstructive pulmonary disease patients who are more active.

Patient persistence with AirFluSal Forspiro was twice the rate of Seretide Diskus.

COPD-related costs reduced from therapies that treat moderate-to-severe COPD.

Long-term culturing of stem cells may improve the treatment of respiratory conditions.

Chronic obstructive pulmonary disease patients who use opioids face a higher risk of respiratory-related death.